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dynamin-related protein 1 increased mitochondrial length, 
retained mitochondrial membrane potentials and reduced 
axonal loss upon capsaicin treatment. These results estab-
lish that mitochondrial stationary site size significantly 
affects axonal integrity and suggest that inhibition of Ca2+-
dependent mitochondrial fission facilitates mitochondrial 
function and axonal survival following activation of axonal 
cationic channels.
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Abbreviations
BAPTA-AM  1,2-bis-(o-Aminophenoxy)-ethane-N,N, 
N′,N′-tetraacetic acid, tetraacetoxymethyl 
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Abstract Capsaicin, an agonist of transient receptor 
potential vanilloid receptor 1, induces axonal degenera-
tion of peripheral sensory nerves and is commonly used to 
treat painful sensory neuropathies. In this study, we inves-
tigated the role of mitochondrial dynamics in capsaicin-
induced axonal degeneration. In capsaicin-treated rodent 
sensory axons, axonal swellings, decreased mitochondrial 
stationary site length and reduced mitochondrial trans-
port preceded axonal degeneration. Increased axoplasmic 
Ca2+ mediated the alterations in mitochondrial length and 
transport. While sustaining mitochondrial transport did not 
reduce axonal swellings in capsaicin-treated axons, pre-
venting mitochondrial fission by overexpression of mutant 
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Introduction
Capsaicin (8-methyl-N-vanillyl-6-noneamide), a chili pep-
per irritant [71], is commonly used as a local analgesic 
in individuals with sensory nerve disorders such as dia-
betic neuropathy [7, 18]. By the activation of the transient 
receptor potential vanilloid receptor 1 (TRPV1), which is 
expressed on sensory axons [9, 43], capsaicin induces a 
nonselective cationic influx, leading to Ca2+-dependent 
desensitization and eventually local denervation of the skin 
[3, 23, 45, 47]. Previous studies have described the effects 
of capsaicin on neuronal cell bodies [16, 36], but less is 
known about the cellular and molecular alterations that 
cause distal axonal degeneration.
Sensory axons that innervate the skin originate from 
dorsal root ganglia (DRG) neurons and can attain a length 
which can exceed 1 m in adult humans. When acutely chal-
lenged by environmental or physiological stress, the integ-
rity of distal axons must be acutely independent of neuronal 
gene transcription [56]. One critical component of axonal 
survival is the generation of ATP, which is essential for 
axonal metabolism, ion homeostasis, and nerve conduction 
[32, 73]. In addition, Na+/Ca2+ overloads that often follow 
energy deficits exert a negative impact on axonal survival 
[67]. An early pathologic hallmark of axonal degeneration 
is the formation of axonal swellings [67, 77]. Focal accu-
mulation of mitochondria and cytoskeleton in axonal swell-
ings suggests that energy failure and Ca2+ overload play 
pivotal roles in axonal degeneration [5, 42, 50].
Mitochondria, the major source of axonal ATP, respond 
to changes in axonal energy demand by altering their size, 
distribution, and motility [13, 61]. The majority of axonal 
mitochondria are stationary and enriched at sites of high 
ATP demand [37, 52]. By fusing with stationary mitochon-
dria, a less abundant motile mitochondrial pool regulates 
stationary mitochondrial turnover and distribution [37, 62]. 
Motile mitochondria can also bud from stationary mito-
chondria by fission [2]. Dynamin-related protein 1 (Drp1), 
a soluble axoplasmic protein, regulates mitochondrial fis-
sion in an energy-dependent manner and a point mutation 
in its GTPase domain abolishes fission upon an increase 
in axoplasmic Ca2+ [12, 26, 41, 66]. While axonal degen-
eration and impaired mitochondrial fusion are features of 
patients with mutations in the mitochondrial proteins OPA1 
and Mitofusin 2 [1, 81], it remains to be determined if 
changes in mitochondrial dynamics and/or rates of trans-
port are involved in capsaicin-induced axonal degeneration.
To explore whether mitochondrial size and/or motil-
ity play a role in capsaicin-induced axonal degeneration, 
we examined sensory axonal pathology following capsai-
cin injection into mouse hindpaws in vivo and investigated 
how axons and axonal mitochondria respond after capsai-
cin treatment of DRG axons in vitro. Capsaicin activation 
of axonal TRPV1 caused axonal ovoid formation and sub-
sequent axonal degeneration in vivo and in vitro. Reduced 
mitochondrial length in axonal swellings, which was 
dependent on Ca2+, suggests a key role of mitochondrial 
fission in capsaicin-induced axonal swellings and degener-
ation. In capsaicin-treated axons, inhibition of axonal mito-
chondrial fission by mutant Drp1 (Drp1K38A) sustains the 
length of mitochondrial stationary sites, increased mito-
chondrial membrane potentials, and significantly reduced 
axonal swellings and axonal degeneration. These data sup-
port the concept that inhibition of mitochondrial fission 
increases axonal mitochondrial size and reduces capsaicin-
induced axonal degeneration.
Materials and methods
Intradermal injections of capsaicin
One hindpaw of 8-week-old male ICR mice (purchased 
from National Taiwan University College of Medicine 
Animal Center) received 2–7 daily intradermal injections 
of 1 % (w/v) capsaicin (CAP, Sigma, St. Louis, MO) dis-
solved in 10 % ethanol, 10 % Tween-80 and saline [27]. 
Vehicle solution was injected into the other hindpaw and 
served as a control. Minor swelling occurred at the injec-
tion site but resolved several hours later. All animal proce-
dures were approved by the animal committee of National 
Taiwan University College of Medicine and were con-
ducted according to Guide for the Care and Use of Labora-
tory Animals from National Research Council.
Embryonic primary DRG culture and drug treatment
Dorsal root ganglia (DRG) cultures were produced from 
E16 to E17 Sprague–Dawley rats and maintained as 
described previously with minor modifications [37]. (See 
Online Resource 1: Supplemental Methods for additional 
details).
DRG cultures were incubated with either capsaicin 
(Sigma) or control solution (DMSO, Sigma) for 15 min, 
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replenished with fresh medium, and further incubated 
for 1.5 or 48 h to evaluate axonal swellings and axonal 
loss, respectively. Serial capsaicin concentrations of 1, 
10, 100 μM and 1 mM were tested to optimize treatment 
conditions and 100 μM capsaicin was used in subsequent 
experiments because it induced axonal ovoid formation 
and alterations in axonal mitochondrial behavior without 
causing axonal loss during the 15-min incubation period. 
In a set of experiments, 10 μM capsazepine (CZP, Sigma), 
a capsaicin antagonist, was added to DRG cultures for 
10 min before the addition of capsaicin or DMSO.
Lentiviral transfection
pLenti6/V5 vectors (Invitrogen) and pLVX vectors (Clon-
tech) were used to transfect DRG neurons in vitro. These 
vectors included constructs to label mitochondria (Mito-
DsRed and Mito-Dendra2), GCaMP3 for detecting axo-
plasmic Ca2+, wild-type (WT) and mutated mitochondrial 
Rho GTPase (Miro) to manipulate mitochondrial motility, 
and WT and mutated Drp1 to manipulate mitochondrial 
fission. Details of these constructs can be found in Online 
Resource 1: Supplemental Methods.
Time-lapse imaging of mitochondrial dynamics, 
axoplasmic Ca2+, and mitochondrial membrane potentials
Time-lapse imaging of mitochondrial dynamics was per-
formed using an inverted confocal microscope as described 
previously [37]. Stationary and motile mitochondria were 
identified and studied with Kymographs generated from 
axons transfected with Mito-DsRed or Mito-Dendra2. 
Increases in axoplasmic Ca2+ were measured by the fluo-
rescence intensity of GCaMP3 as described previously [52] 
and the membrane potential of axonal mitochondria was 
determined in DRG cultures stained with tetramethylrho-
damine methyl ester (TMRM, Invitrogen) as previously 
described with some modifications [75]. Details of these 
methods and other experimental conditions are described in 
Online Resource 1: Supplemental Methods.
Axonal pathology
Hindpaw skin and associated medial plantar nerves from 
the injection sites were resected after transcardial perfusion 
with 4 % paraformaldehyde for light microscopy and 5 % 
glutaraldehyde for electron microscopy. DRG cultures were 
similarly immersion fixed. Epidermal and dermal nerves in 
the hindpaw skin and DRG cultures were immunochemi-
cally stained for protein gene product 9.5 (PGP9.5) [31, 70] 
and β-tubulin isotype III antibodies as markers for axonal 
integrity. Axonal swellings were defined as axonal sphe-
roids which had single or dual axonal connections and were 
at least twice as wide as adjacent areas of the same axons. 
Mitochondrial morphology in dermal axons was also evalu-
ated with the mitochondrial marker Oxphos ComplexIV 
Subunit I (COXI) and with PGP9.5. Tissue fixed with gluta-
raldehyde was processed to Epon, sectioned on an ultrami-
crotome, and examined in an electron microscope. Further 
details of these methods are described in Online Resource 
1: Supplemental Methods.
Experimental design and statistical analysis
For in vivo studies, we compared axonal pathologies in 
hindpaws injected with capsaicin and control solution 
(Vehicle) from at least 3 mice. Axonal swellings and mito-
chondrial length in DRG cultures treated with either cap-
saicin or control solution (DMSO) were determined from at 
least three replicates. Results with under- and overexpres-
sion of Miro or Drp1, GCaMP3 and TMRM intensity were 
obtained from at least three replicates. Statistical analyses, 
including evaluations of normality, were conducted with 
Prism 3.0 (GraphPad Software, La Jolla, CA). For non-
parametric Mann–Whitney tests and Kruskal–Wallis tests 
with Dunn’s multiple comparisons, values are presented 
as median + interquartile range. For parametric unpaired 
t tests and one-way ANOVAs with Bonferroni corrections, 
values are presented as mean + standard deviation (SD). 
Comparisons of mitochondrial length between capsaicin 
and control groups were performed with a chi-square test. 
Correlations between dermal nerve density with β-tubulin 
III and PGP9.5 staining and length of mitochondria and 
axonal swellings were performed with Pearson’s correla-
tion tests and Spearman’s correlation tests, respectively.
Results
Capsaicin induces axonal ovoid formation and axonal loss 
in vivo and in vitro
We investigated capsaicin-induced pathologies in sen-
sory axons in vivo following daily intradermal injections 
of capsaicin into mouse hindpaws (Fig. 1a). After 3 daily 
capsaicin injections, there was a significant increase in 
PGP9.5-positive axonal swellings in the epidermis com-
pared to vehicle-injected hindpaws (Fig. 1b1–b4). The 
capsaicin-induced reduction in PGP9.5-positive epidermal 
nerve density was apparent after 7 daily capsaicin injec-
tions (Fig. 1b5, b6). Loss of PGP9.5 staining was due to 
axonal loss and not due to reduced PGP9.5 expression in 
intact axons, as β-tubulin isotype III antibodies produced 
identical staining patterns as PGP9.5 antibodies (Online 
Resource 2). Electron microscopic analysis of medial plan-
tar nerves innervating hindpaws detected degenerating 
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axons following 7 daily capsaicin injections (Fig. 1c1–c4, 
Online Resource 3). Compared to control unmyelinated 
axons, which contained intact mitochondria and densely 
packed neurofilaments (Fig. 1c1), unmyelinated axons in 
capsaicin-treated mice contained swollen mitochondria 
with reduced cristae and pale axoplasm with decreased 
neurofilament densities (Fig. 1c2). The percentage of 
degenerating axons was significantly increased (Fig. 1c3) 
Fig. 1  Capsaicin treatment induces axonal degeneration in vivo. a 
Male ICR mice received daily hindpaw intradermal injections of cap-
saicin (CAP) or vehicle (control) solutions. Unmyelinated axons in 
the medial plantar nerves (red dashed box) and their nerve terminals 
in the dermis and epidermis (blue dashed box) were examined with 
protein gene product 9.5 (PGP9.5) immunohistochemistry and elec-
tron microscopy. DRG dorsal root ganglia. b Axonal pathologies in 
epidermal nerves after daily capsaicin injections. b1 Epidermal nerve 
terminals were evenly distributed in controls (b1 inset, arrowheads). 
Following 2 (b2) and 3 (b3) daily capsaicin injections, swelling of epi-
dermal axons was significantly increased (b4). Epidermal nerve den-
sity (b5) was significantly reduced (b6) after 7 daily capsaicin (CAP 
D7) injections (**P < 0.01 by Kruskal–Wallis test and Dunn’s mul-
tiple comparison test). D day. c Electron microscopic images dem-
onstrate unmyelinated axonal degeneration in medial plantar nerves 
after 7 daily capsaicin injections. Compared to control nerves, which 
displayed normal axoplasm (c1), unmyelinated axons treated with 
capsaicin displayed characteristics of degeneration including swol-
len mitochondria with reduced cristae (c2, inset) and pale axoplasm 
(c2, arrowhead). Degenerating axons were increased (c3) and axonal 
density was decreased (c4) in capsaicin-injected nerves (*P < 0.05, 
**P < 0.01 by Mann–Whitney test and unpaired t test). The numbers 
of subjects are shown in the bar graphs. Scale Bars b1–b3, b5: 25 μm; 
b1–b3, b5 insets 10 μm; c1, c2 500 nm; c1, c2 insets 100 nm
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and the density of unmyelinated axons was significantly 
decreased (Fig. 1c4) following 7 daily capsaicin injections. 
Capsaicin-treated Remak bundles contained fewer unmy-
elinated axons and had an increased percentage of empty 
collagen pockets, supporting axonal degeneration (Online 
Resource 4a, b). Dermal axonal density was also decreased 
following 7 daily injections of capsaicin (Fig. 2a1–a3). The 
proportion of mitochondria <1 μm in length was increased 
significantly in dermal nerves after capsaicin treatment 
compared to vehicle-treated dermal nerves (Fig. 2b1–b3). 
These results indicated that formation of axonal swellings 
and smaller axonal mitochondria preceded axonal degen-
eration caused by 7 daily capsaicin hindpaw injections.
We next investigated the role of mitochondria in capsa-
icin-induced axonal pathologies in primary DRG cultures. 
Figure 3a summarizes the general approach to our in vitro 
studies. The capsaicin receptor, TRPV1, was detected on 
the surface of DRG neurons and axons (Fig. 3b). PGP9.5 
immunostaining was used to identify unmyelinated axons 
(Fig. 3c–g) and axons were continuous and uniform in 
width upon DMSO treatment (Fig. 3c). In contrast, after 
capsaicin treatment, axons exhibited multiple swellings 
followed by axonal loss in a dose-dependent and time-
dependent manner (Online Resource 5a–h). Based upon 
this dose response study, 100 μM capsaicin was used for 
all subsequent experiments. The number of axonal swell-
ings per unit axonal length was significantly increased in 
the capsaicin group compared to the DMSO group (Fig. 3c, 
d, h). In addition to axonal ovoid formation, axonal loss 
in DRG cultures increased significantly 48 h after capsai-
cin treatment (Fig. 3g, i). Thus, capsaicin-induced axonal 
pathology and axonal degeneration in vitro were similar to 
those found in vivo.
The axonal ovoid formation and subsequent axonal loss 
in the in vitro DRG experiments described above may result 
from the activation of TRPV1 by capsaicin on axons and/
or neuronal cell bodies. Pretreatment with 10 μM capsaze-
pine (CZP), a competitive antagonist of TRPV1, for 10 min 
prior to the addition of capsaicin significantly decreased 
axonal ovoid formation (Fig. 3e, f, h) and rescued axonal 
loss (Online Resource 6a1–a4), indicating that activation of 
TRPV1 by capsaicin induced axonal pathology in vitro. To 
investigate if capsaicin can directly induce axonal pathology 
and degeneration by binding to axonal TRPV1, we estab-
lished DRG cultures in a compartmental microfluidic sys-
tem that isolates the environment of distal axons from that 
of neuronal cell bodies [69]. 90 min following capsaicin 
administration (15 min) to the Xona compartment that con-
tained only DRG axons, axonal ovoid formation was more 
prominent in the axon chamber than in the soma chamber 
(Fig. 3j, k, axon vs. soma, 4.92 ± 1.73 vs. 1.15 ± 0.52 
ovoids/mm, P = 0.0226). These results provide direct evi-
dence that capsaicin causes formation of axonal swellings in 
DRG cultures by activating axonal TRPV1.
Fig. 2  Capsaicin shortens mitochondria and induces axonal degen-
eration. Dermal axons were examined with protein gene product 9.5 
(PGP9.5, green) and the mitochondrial marker, Oxphos ComplexIV 
Subunit I (COXI, red) immunohistochemistry. a1, a2 Confocal analy-
ses detected decreased abundance of the dermal nerve plexus after 7 
daily capsaicin injections (CAP) (a2) compared to controls (a1, Cont). 
Dermal nerves were continuous (a1, arrowheads) in controls. Axons 
became beaded (a2, double arrowheads) and reduced in number fol-
lowing capsaicin injections (a3) (**P < 0.01 by Mann–Whitney test). 
The numbers of subjects are shown in the bar graphs. b1, b2 COXI-
positive mitochondria (COXI) in PGP9.5-positive dermal nerves 
(PGP9.5) were shorter following capsaicin treatment (b2, inset) com-
pared to control nerves (b1, inset). b3 Histograms show reduced mito-
chondrial length after capsaicin treatment (χ2 = 144.3, P < 0.0001 by 
chi-square test). Mitochondria from four subjects were pooled. Scale 
bars a1, a2 50 μm; b1, b2 10 μm; b1, b2 insets 2.5 μm
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Capsaicin induces mitochondrial fission and reduces 
mitochondrial transport
Abnormal mitochondria in unmyelinated axons of capsa-
icin-treated medial plantar nerves (Fig. 1c1, c2 inset) and 
dermal nerves of hindpaw skin (Fig. 2b3) indicate that 
mitochondrial size and/or distribution might contribute to 
capsaicin-induced axonal pathology and degeneration. To 
explore these possibilities, we transfected 3- to 4-week-
old DRG neurons with mitochondria-targeted fluorescent 
proteins (Mito-Dendra2 or Mito-DsRed) and examined the 
distribution and morphology of axonal mitochondria with 
Fig. 3  Capsaicin treatment causes axonal ovoid formation and 
axonal degeneration in vitro. a Experimental paradigm of in vitro 
capsaicin treatment of dorsal root ganglia (DRG) cultures. DRG cul-
tures were prepared from E16 to E17 rat embryos (1), transfected 
with lentiviral vectors carrying mitochondria-targeted fluorescent 
protein (Mito-Dendra2) (2) and then transfected with lentivirus car-
rying either Miro or Drp1 (3). Time-lapse imaging of mitochondria 
was taken before (4), during (5), and after treatment with capsaicin 
(CAP) or vehicle (DMSO) (6). Cells were washed and then fixed 
for immunostaining with PGP9.5. Axonal swellings and mitochon-
drial morphology were analyzed (7). IHC immunohistochemistry. b 
DRG neurons (double arrowheads) and a representative axon (arrow-
heads) were positive for TRPV1, whereas non-neuronal cells were 
not. DIC differential interference contrast. c, d Immunostaining of 
DRG axons for PGP9.5 shows multiple axonal swellings after cap-
saicin treatment (d, arrowheads) but not after DMSO treatment (c). 
e, f Pretreatment with the capsaicin antagonist capsazepine (CZP) 
decreased axonal ovoid formation upon capsaicin treatment. g The 
number of axons was decreased 48 h after capsaicin treatment. h 
Axonal swellings were increased after capsaicin compared to DMSO 
treatment and CZP significantly decreased the number of axonal 
swellings (*P < 0.05; **P < 0.01 by Kruskal–Wallis test and Dunn’s 
multiple comparison test). i Bar graph shows decreased axonal den-
sity normalized to DMSO 48 h after capsaicin treatment (*P < 0.05; 
**P < 0.01 by Kruskal–Wallis test and Dunn’s multiple comparison 
test). j In the Xona microfluidic system, DRG neurons were seeded in 
a soma chamber (blue) and extended axons into a separated chamber 
(pink), where capsaicin was applied (arrow). k Application of capsai-
cin in the axonal chamber induced axonal swellings (arrowheads). 
Axonal ovoid formation in the soma chamber was less prominent. 
The numbers of independent replicates are shown in the bar graphs. 
Scale bars: b 25 μm; c–g 10 μm; k 5 μm
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time-lapse image recording 2 weeks after the transfection 
(Fig. 3a). Compared to DMSO-treated cultures (Fig. 4a–c), 
capsaicin treatment (Fig. 4d–f) significantly reduced the 
length of axonal mitochondria (Fig. 4g1). The proportion 
of mitochondria <1 μm in length increased upon capsaicin 
treatment (Fig. 4g2). Interestingly, 61.5 % of axonal swell-
ings (67/109) in 34 axons contained mitochondria (Fig. 4a–
f) and the mitochondrial density [mitochondrial number/
axon length (mm)] within axonal swellings was signifi-
cantly higher than that in axonal regions without swell-
ings (ovoid portion vs. non-ovoid portion, 400 ± 230.7 
vs. 74.18 ± 46.3, P < 0.0001). Since reduced mitochon-
drial length has been associated with decreased fusion or 
increased fission [11], the decreased mitochondrial length 
in capsaicin-treated cultures suggested that mitochondrial 
dynamics were affected upon capsaicin treatment. Thus, 
we next compared the size of stationary mitochondrial sites 
and the percentage of axons containing motile mitochon-
dria in axons with time-lapse images taken before and after 
capsaicin treatment. DMSO treatment had no effect on 
mitochondrial stationary site size or mitochondrial trans-
port (Fig. 4h–j). In contrast, the percentage of axons with 
motile mitochondria decreased significantly (Fig. 4i) and 
the length of mitochondrial stationary sites was reduced 
(Fig. 4j) upon capsaicin treatment (Fig. 4h). Pretreatment 
of DRG cultures with the TRPV1 antagonist CZP prior to 
capsaicin administration rescued mitochondrial motility 
and mitochondrial stationary site length (Online Resource 
6b1–b3), indicating that capsaicin regulates mitochondrial 
dynamics through activation of TRPV1. Expression of 
mitochondria-targeted fluorescent proteins was found in 
a small number of non-neuronal cells, but mitochondrial 
size in these cells did not change upon capsaicin treat-
ment (DMSO vs. CAP, 6.24 ± 2.93 vs. 4.76 ± 1.18 μm, 
P = 0.4641). In summary, capsaicin treatment of DRG 
cultures reduced mitochondrial transport and decreased the 
length of axonal mitochondrial stationary sites via TRPV1 
activation.
Cytosolic Ca2+ can regulate mitochondrial dynamics, 
including mitochondrial motility and mitochondrial sta-
tionary site size [26, 46, 60]. To test if axoplasmic Ca2+ 
is increased by capsaicin treatment and is associated with 
mitochondrial alterations, we doubly transfected DRG neu-
rons with a lentivirus carrying the Ca2+ indicator protein 
Fig. 4  Capsaicin causes fragmentation and reduced motility of 
axonal mitochondria. a–f Capsaicin- and DMSO-treated axons 
were transfected with Mito-Dendra2 (Mito), examined by time-
lapse imaging, and then stained with PGP9.5 antibodies. Compared 
to DMSO-treated nerves (b, c, arrowheads), axonal swellings (d, 
arrows) increased and mitochondria became shorter in capsaicin-
treated cultures (e, f, arrowheads). g1, g2 Mean mitochondrial length 
in DRG axons was significantly reduced after capsaicin treatment. 
When axons were sub-grouped according to their mean mitochon-
drial length, the proportion of axons with mean mitochondrial length 
<1 μm was increased upon capsaicin treatment (***P = 0.0001 by 
Mann–Whitney test. χ2 = 34.07, P < 0.0001 by chi-square test). h–j 
Representative frames of time-lapse images of axonal mitochon-
drial transport and resulting kymographs before and 1 h (1 h) after 
DMSO or capsaicin treatment. The length (arrows) and motility 
(arrowheads) of mitochondria were maintained after DMSO but were 
decreased after capsaicin treatment (***P < 0.0001 by Kruskal–Wal-
lis test and Dunn’s multiple comparison test). The numbers of axons 
are shown in the bar graphs. Scale bars a–f 10 μm; h 5 μm
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GCaMP3 and Mito-DsRed. GCaMP3 contains a single per-
mutated EGFP fused to the calmodulin-binding domain of 
the myosin light-chain kinase. Thus, an increase in cytosolic 
Ca2+ increases EGFP fluorescence [49]. Changes in axo-
plasmic Ca2+ levels with time-lapse images are indicated by 
EGFP fluorescence before and immediately after capsaicin 
exposure (Fig. 5a). The fluorescence intensity of GCaMP3 
in DRG axons was generally weak (Fig. 5b–d). The fluores-
cence intensity was significantly increased in axons treated 
with capsaicin (Fig. 5c1, c2, e) but was not altered after the 
addition of DMSO (Fig. 5b2). GCaMP3 was expressed by 
a small number of non-neuronal cells in DRG cultures, but 
the fluorescence intensity in those cells did not change upon 
capsaicin treatment [Before vs. CAP, ΔF/F0 (%) = 0 ± 0 
vs. −18.32 ± 48.41 %, P = 0.4512], indicating that the 
effect of capsaicin was neuron specific. To determine 
whether this Ca2+ increase led to altered mitochondrial 
motility and stationary site size, the Ca2+ chelators BAPTA-
AM and EGTA were added to the cultures prior to capsai-
cin treatment. Depletion of free Ca2+ in DRG cultures pre-
vented the increase in GCaMP3 fluorescence intensity upon 
capsaicin treatment (Fig. 5d1, d2, e). In addition, mitochon-
drial stationary site sizes were unchanged and 58.5 % of 
axons maintained motile mitochondria when cultures were 
pretreated with Ca2+ chelators before capsaicin treatment 
(Fig. 5f–h). These results indicate that a capsaicin-induced 
increase in axoplasmic Ca2+ alters axonal mitochondrial 
stationary site size and mitochondrial motility.
Fig. 5  Capsaicin treatment increases axonal Ca2+ and fragments 
axonal mitochondria. a Experimental paradigm of axoplasmic Ca2+ 
evaluation following capsaicin treatment. Dorsal root ganglia (DRG) 
cultures were transfected with a calcium indicator, GCaMP3 (1). 
GCaMP3 activation (fluorescence intensity) (2) was observed before 
(3) and during (4) capsaicin (CAP) or DMSO treatment. b–e Time-
lapse images show that axoplasmic fluorescence of GCaMP3 (b1, c1, 
d1, arrowheads) was increased 1 min (1 min) after capsaicin treat-
ment (c2, arrowheads), but not after DMSO treatment (b2, arrow-
heads) or when the culture was pretreated with the Ca2+ chelators 
BAPTA-AM and EGTA (CAP + chelators; d2, arrowheads). The 
increase in fluorescent intensity in each axon was normalized to its 
pretest intensity (Before) (***P < 0.001 by Kruskal–Wallis test and 
Dunn’s multiple comparison test). Box plots show minimum, median 
and maximum in e. f–h Analyses of mitochondrial behavior and 
GCaMP3 intensity in time-lapse images detected shortened mito-
chondrial stationary sites (g) and reduced mitochondrial transport (h) 
after capsaicin treatment when compared to DMSO or Ca2+ chelator 
treatments (***P < 0.0001 by Kruskal–Wallis test and Dunn’s mul-
tiple comparison test). The numbers of axons analyzed are shown in 
corresponding bar graphs. Scale bars b1–d2 10 μm; f 5 μm
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Inhibition of mitochondrial fission, but not sustained 
motility of axonal mitochondria, reduces axonal ovoid 
formation upon capsaicin treatment
Given that axonal mitochondrial transport was decreased 
by capsaicin treatment (Fig. 4i), we evaluated the contri-
bution of mitochondrial motility to axonal ovoid formation 
upon capsaicin treatment by focusing on mitochondrial 
Rho GTPase (Miro), a mitochondrial outer membrane pro-
tein responsible for mitochondrial motility. DRG neurons 
were transfected with wild-type Miro (MiroWT) or an EF-
hand Miro mutant (MiroKK) that prevents a Ca2+-induced 
reduction in axonal mitochondrial transport [46, 60, 78]. 
For visualizing transfected axons, the N′-terminal myc-
tagged Miro vectors contained a sequence for a reporter 
fluorescent protein mCherry driven by internal ribosomal 
entry site (IRES). Upon Miro transfection, axons became 
positive for mCherry. In addition, myc-immunostaining in 
mCherry-positive axons confirmed the expression of myc-
tagged Miro in mitochondria positive for Mito-Dendra2 
[20] (Online Resource 7a–d). Under time-lapse imaging, 
the percentage of axons with motile mitochondria was 
decreased in capsaicin-treated cultures transfected with 
MiroWT, as observed in control cultures without viral 
transfection (Online Resource 7e, f). MiroWT overex-
pression in DRG axons did not alter axonal ovoid forma-
tion upon capsaicin treatment (Online Resource 7g–i, m), 
suggesting the overexpression of MiroWT, which medi-
ated Ca2+-induced mitochondrial stopping, did not worsen 
capsaicin-induced axonal pathology. In contrast, 63.8 % of 
axons with MiroKK overexpression contained motile mito-
chondria after capsaicin treatment. However, axonal ovoid 
formation was not reduced in capsaicin-treated axons that 
overexpressed MiroKK (Online Resource 7j–l, m). These 
results indicate that MiroKK overexpression sustains 
motile mitochondria but did not significantly alter axonal 
ovoid formation upon capsaicin treatment.
The decreased size of mitochondrial stationary sites 
observed in capsaicin-treated axons may reflect an altered 
balance between mitochondrial fusion and fission. To ask 
whether preventing mitochondrial fission contributes to 
axonal pathologies, Drp1 was overexpressed in DRG cul-
tures. When recruited upon increases in cytosolic Ca2+, 
Drp1 mediates mitochondrial fission [10, 19, 26]. Mito-
chondrial fission in DRG cultures could be modulated by 
overexpression of wild-type (Drp1WT) or a dominant-
negative mutant Drp1 (Drp1K38A), which inhibits Drp1-
mediated mitochondrial fission [19, 66]. The Drp1 vectors 
also contained a mCherry construct to identify Drp1-over-
expressing axons. Following capsaicin treatment, axonal 
mitochondria were shortened (Fig. 6a–c, g) and the number 
of axonal swellings was increased (Fig. 6h) in cultures with 
overexpression of Drp1WT. In contrast, capsaicin-treated 
axons that overexpressed Drp1K38A contained signifi-
cantly longer mitochondria (Fig. 6d–f, g) and fewer axonal 
swellings (Fig. 6h) compared to axons transfected with 
Drp1WT (Fig. 6a–c, g). When the mean of mitochondrial 
length and the number of swellings in each axon were plot-
ted in a combined dataset from all cultures, mitochondrial 
length was inversely correlated with the number of axonal 
swellings (Fig. 6i); i.e., axons with longer mitochondria 
contained fewer axonal swellings. Furthermore, DRG cul-
tures overexpressing Drp1K38A retained more axons 48 h 
after capsaicin treatment (Fig. 7c1, c2, d) compared to DRG 
cultures without transfection or with Drp1WT overexpres-
sion (Fig. 7a, b, d). Taken together, these results demon-
strate that inhibition of mitochondrial fission by Drp1K38A 
resulted in sustained mitochondrial length, reduced axonal 
ovoid formation, and less axonal degeneration upon capsai-
cin treatment.
Inhibited fission of axonal mitochondria retains 
mitochondrial membrane potential upon capsaicin 
treatment
The inverse correlation between mitochondrial length and 
axonal degeneration upon capsaicin treatment suggests that 
inhibition of mitochondrial fission reduces axonal ovoid 
formation and axonal degeneration by retaining functional 
mitochondria upon axonal injury. To evaluate the effect of 
Drp1K38A overexpression on mitochondrial function after 
capsaicin treatment, we stained Mito-Dendra2-transfected 
cultures with mitochondrial membrane potential indica-
tor tetramethylrhodamine methyl ester (TMRM). TMRM 
ubiquitously stained mitochondria in all cell types in DRG 
cultures (Fig. 8a, b), but mitochondrial TMRM intensity 
did not change after capsaicin treatment in non-neuronal 
cells where mitochondria were not labeled with Mito-
Dendra2 [Before vs. CAP (Fm/Fc)0 = 163.9 ± 211.8 vs. 
(Fm/Fc)cap = 179.1 ± 216.2, P = 0.1748]. Therefore, using 
Xona platforms, we evaluated TMRM fluorescence within 
axonal stationary sites labeled with Mito-Dendra2 (Fig. 8a, 
b). Although TMRM intensity of mitochondria in cultures 
with Drp1K38A overexpression was significantly higher 
before capsaicin treatment compared to control cultures 
(Fig. 8d), there was no correlation between stationary site 
length and TMRM intensity under basal conditions. While 
axonal mitochondria in control cultures became shortened 
and lost TMRM fluorescence upon capsaicin treatment, 
axonal mitochondria in cultures with Drp1K38A overex-
pression retained their length and TMRM fluorescence after 
capsaicin treatment (Fig. 8a–c). Importantly, upon cap-
saicin treatment, mitochondrial length was correlated with 
TMRM intensity in axons that overexpressed Drp1K38A; 
63 % of mitochondria with a length between 2 and 4 μm 
retained TMRM intensity after capsaicin treatment 
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(Fig. 8e). These findings support the concept that inhibi-
tion of mitochondrial fission by Drp1K38A overexpression 
retains axonal mitochondrial membrane potential and con-
tributes to axonal survival upon capsaicin treatment.
Discussion
The present study investigated how activation of the 
TRPV1 receptor causes degeneration of sensory axonal ter-
minals. We show that capsaicin activation of axonal TRPV1 
increases axoplasmic Ca2+ and decreases (1) the size of 
mitochondrial stationary sites, (2) the percentage of axons 
with motile mitochondria, and (3) mitochondrial membrane 
potentials. These alterations in axoplasm paralleled axonal 
ovoid formation and preceded axonal degeneration. Rescue 
of mitochondrial transport did not rescue axonal ovoid for-
mation or axonal degeneration. Inhibition of mitochondrial 
fission, however, increased mitochondrial stationary site 
sizes, reduced axonal ovoid formation and axonal degener-
ation, and maintained mitochondrial membrane potentials 
in capsaicin-treated nerves. These results establish a pivotal 
role of mitochondrial dynamics during axonal ovoid forma-
tion and degeneration, and provide evidence that modula-
tion of mitochondrial dynamics can reduce axonal degen-
eration caused by capsaicin.
In this study, we demonstrate axonal ovoid formation 
as a pathologic intermediate preceding capsaicin-induced 
axonal degeneration. Formation of axonal swellings is 
thought to predict subsequent axonal degeneration in mam-
mals [29, 39, 42]. In the current report, axonal swellings 
formed upon capsaicin treatment in a dose-dependent man-
ner followed by axonal loss in vivo and in vitro. In addition, 
reduced axonal ovoid formation paralleled reduced axonal 
loss. Based on these findings, axonal ovoid formation may 
be regarded as an early indicator of axonal degeneration.
Fig. 6  Overexpression of mutant Drp1K38A reduces axonal ovoid 
formation following capsaicin treatment. a–f Confocal images of 
axonal Mito-Dendra2 (Mito) labeling and PGP9.5 immunostaining 
after capsaicin treatment (CAP). The axonal swellings and shorter 
mitochondria (a–c, arrowheads) that were prominent in axons trans-
fected with wild-type Drp1 (WT) were significantly reduced (d–f, 
arrows) in axons transfected with mutant Drp1K38A (K38A). g The 
mean length of axonal mitochondria after capsaicin treatment was 
significantly increased in Drp1K38A-transfected axons compared 
to axons transfected with Drp1WT (**P < 0.01; ***P < 0.0001 by 
Kruskal–Wallis test and Dunn’s multiple comparison test). h Capsai-
cin treatment significantly increased the number of axonal swellings 
in Drp1WT-transfected axons when compared to mutant Drp1K38A-
transfected axons (***P < 0.0001 by Kruskal–Wallis test and Dunn’s 
multiple comparison test). i Mitochondrial length was inversely 
correlated with the number of axonal swellings in control (black), 
Drp1WT-transfected (red) and mutated Drp1K38A-transfected axons 
(blue) (Spearman r = −0.6214). The numbers of axons analyzed are 
shown in the bar graphs. Scale bars a–f 5 μm
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Fig. 7  Drp1K38A mutant overexpression improves axonal survival 
following capsaicin treatment in vitro. a1–c2 Confocal images of con-
trol (control; a1, a2), wild-type Drp1-transfected (Drp1WT; b1, b2) 
and mutated Drp1 (Drp1K38A; c1, c2)-transfected dorsal root gan-
glia (DRG) cultures immunostained for PGP9.5 48 h after capsaicin 
(CAP) or DMSO treatment. Capsaicin induced significant axonal loss 
in control (a1, a2, d) and Drp1WT-transfected (b1, b2, d) cultures. 
Axonal density was rescued in Drp1K38A-transfected (c1, c2, d) cul-
tures (***P < 0.0001, One-Way ANOVA). The analysis was based on 
3–4 randomly chosen fields in each replicate. Dots represent number 
of replicates. Scale bars a1–c2 100 μm
Fig. 8  Mutant Drp1K38A overexpression retains mitochondrial 
membrane potential upon capsaicin treatment. a, b Time-lapse 
images of axonal mitochondria labeled with Mito-Dendra2 (Mito) 
and stained with TMRM for mitochondrial membrane potential. 
TMRM labeling co-localized with axonal mitochondria (arrow-
heads). While mitochondria in control (control, Cont) lost TMRM 
intensity after capsaicin treatment (CAP) (arrows), TMRM intensity 
was retained in Drp1K38A-transfected dorsal root ganglia (DRG) 
cultures (K38A) (double arrowheads). c Bar graphs show that K38A-
overexpressed axons significantly retained TMRM intensity after 
capsaicin compared to control axons (**P < 0.01 by Mann–Whitney 
test). d Mitochondrial TMRM intensity was significantly increased 
in axons transfected with mutated Drp1K38A before capsaicin treat-
ment (**P < 0.01 by Mann–Whitney test). e Stationary mitochondrial 
sites with Drp1K38A overexpression sub-grouped according to their 
lengths were plotted against the percentage of mitochondria with 
their TMRM intensity exceeding average (Fm/Fa)0. Bar graphs show 
that axonal mitochondria of 2–4 μm in length retained membrane 
potential in K38A-overexpressed axons after capsaicin treatment 
(χ2 = 33.69, P < 0.0001 by chi-square test). The numbers of axons 
in c and mitochondrial stationary sites in d are shown. Scale bars 
a, b 10 μm
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This report focused on the effects of capsaicin on mito-
chondrial integrity and axonal degeneration. In addition 
to increasing axonal Ca2+, capsaicin also affects non-neu-
ronal cells, including mast cells [8, 58], which may induce 
neurogenic inflammation and negatively influence axonal 
integrity. While this issue requires further investigation in 
vivo, mast cells are not present in DRG cultures and will 
not influence the outcomes of capsaicin-induced axonal 
degeneration.
Local injections of capsaicin in the mouse hindpaw 
reduced axonal mitochondrial length, increased axonal 
ovoid formation, and increased distal sensory axonal 
degeneration. To explore the role of mitochondrial dynam-
ics during capsaicin-induced axonal degeneration, we 
established an in vitro model which mimics the axonal 
pathologies in vivo. An important question is whether cap-
saicin-induced axonal pathology in vitro mimics capsaicin-
induced axonal pathology in vivo. TRPV1 was detected on 
DRG axons in vitro and capsaicin induced axonal swell-
ings and axonal degeneration in a dose-dependent manner. 
Using the Xona microfluidic culture platform, we estab-
lished that capsaicin induced axonal ovoid formation by 
activation of TRPV1 on axons that were segregated from 
neuronal cell bodies. Inhibition of capsaicin activation of 
axonal TRPV1 with the capsaicin antagonist CZP signifi-
cantly reduced axonal swellings, mitochondrial station-
ary site shortening and axonal degeneration in our in vitro 
system. Similarities between basic aspects of capsaicin-
induced axonal pathology in vivo and in vitro support the 
use of our in vitro system to study mitochondrial dynamics 
with confocal imaging.
This current report provides links between mitochon-
drial dynamics and the pre-degeneration status of nerve 
fibers, suggesting that altered mitochondrial dynamics, 
especially shortening of mitochondria, play key roles in 
axonal ovoid formation. Post-translational modifications 
of Drp1 and subsequent activation of signaling cascades, 
including calcineurin and Ca2+/calmodulin-dependent pro-
tein kinase I alpha (CaMKIalpha), regulates Ca2+-mediated 
mitochondrial fission [10, 12, 14, 26]. Drp1 is essential 
for normal brain development and total ablation of Drp1 
is embryonic lethal and causes severe neurodegeneration 
[33, 76]. Aberrant activation of Drp1 is thought to trigger 
neuronal apoptosis in several neurodegenerative diseases, 
including Huntington’s disease and Alzheimer’s disease, 
and may be related to the mitochondrial release of the pro-
apoptotic molecule Bax [14, 25]. While previous studies 
focused on Drp1 in neuronal cell bodies and its role in neu-
ronal death, we investigated the role of Drp1 during axonal 
degeneration caused by receptor-mediated Ca2+ influx. 
We used a dominant interfering mutant Drp1K38A, which 
prevents shortening of axonal mitochondria by inhibiting 
mitochondrial fission [4, 55, 74]. Our data demonstrate 
an inverse correlation between mitochondrial length and 
axonal degeneration. Sustained mitochondrial length cor-
related with increased mitochondrial membrane potentials 
and reduced axonal pathology caused by capsaicin treat-
ment. Mutant Drp1K38A overexpression, which reduces 
mitochondrial fission, increased mitochondrial length and 
significantly reduced capsaicin-induced axonal loss from 
~50 to ~15 % (Fig. 7d). Overexpression of wild-type Drp1 
reduced mitochondrial length (Fig. 6g) but did not change 
axonal survival (Fig. 7d) following capsaicin treatment, 
supporting previous studies reporting that Drp1 overexpres-
sion can increase fragmentation of mitochondria [40, 68] 
but does not change cell viability, even at high levels of 
expression [68]. On the other hand, mutant Drp1 will com-
pete with wild-type Drp1 and reduce mitochondrial fission 
and axonal degeneration following capsaicin treatment, 
resulting in increased mitochondrial length (Fig. 6g; [44]).
In our study, shorter stationary mitochondrial sites 
produced by excessive fission disrupted axonal integrity, 
whereas longer stationary sites produced by preventing fis-
sion decreased axonal damage upon capsaicin treatment. 
This implies that longer mitochondrial stationary sites are 
an indication of better mitochondrial function. Capsaicin 
reduced the size of mitochondria and decreased TMRM 
mitochondrial intensity in control cultures; however, when 
mutant Drp1 was overexpressed in capsaicin-treated axons, 
mitochondrial length and TMRM mitochondrial poten-
tial were not decreased to the same extent as in capsaicin-
treated control cultures (Fig. 8e). Longer stationary sites 
may have a greater capacity for buffering axoplasmic Ca2+ 
increases upon capsaicin treatment. Longer mitochondria 
may retain the ability to produce more ATP during and/or 
following capsaicin treatment and thereby decrease axonal 
damage. Mitochondrial fusion and elongation are beneficial 
under starvation and stress caused by UV irradiation and 
this has been attributed to increased ATP production [24, 
57, 72]. In addition, mitochondrial swelling and reduced 
mitochondrial cristae are indicative of mitochondrial dys-
function and may contribute to decreased axonal ATP 
production and reduced axonal survival [50, 54, 60]. The 
dynamin-related proteins, including OPA1 and Drp1, have 
been shown to regulate changes in cristae during apopto-
sis [21, 22]. Inhibition of mitochondrial fission by mutant 
Drp1 may help retain cristae morphology and mitochon-
drial functions upon capsaicin treatment. A fusion-prone 
shift in the balance between mitochondrial fusion and fis-
sion by temporarily suppressing Drp1 function or its asso-
ciated regulators may provide a therapeutic target for acute 
axonal injury caused by Ca2+ overload and energy deficits 
[34].
Due to significant mitochondrial transport reduction 
induced by capsaicin treatment, we asked whether chang-
ing mitochondrial motility by overexpressing MiroWT 
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or MiroKK would alter axonal ovoid formation induced 
by capsaicin. Movement of mitochondria relies on their 
binding to the cytoskeleton through adaptors and Miro is 
a key regulator in Ca2+-mediated mitochondrial stopping. 
MiroWT overexpression did not rescue or worsen axonal 
ovoid formation. On the other hand, overexpression of 
MiroKK sustained mitochondrial motility but did not res-
cue axonal ovoid formation upon capsaicin treatment. 
While it is likely that chronic alterations in mitochondrial 
transport can have a negative impact on mitochondria 
turnover and axonal viability, our data support the concept 
that acute changes in mitochondrial transport do not affect 
axonal viability.
Our results establish a key role of mitochondrial size 
in capsaicin-induced axonal degeneration. Other mecha-
nisms dependent on mitochondria, including autophagy/
mitophagy, may also have an impact on capsaicin-induced 
axonal degeneration. Uncontrolled autophagy/mitophagy 
has been shown to contribute to axonal degeneration in 
neurodegenerative diseases [79, 80]. We did not observe 
autophagy in electron microscopic images of capsaicin-
treated nerves in vivo nor did we observe autophagosomes 
in capsaicin-treated dermal nerves with Light Chain 3 (LC3) 
immunostaining, which is an indicator of autophagy (Online 
Resource 8). It is possible that axoplasmic Ca2+ increases 
induced by capsaicin may cause autophagy and/or impair 
axonal integrity [30] at time points not analyzed in the cur-
rent study. Further studies, including western blotting for 
LC3 and live imaging for GFP-LC3, are needed to evaluate 
autophagy/mitophagy in capsaicin-induced axonal loss.
This study highlights the importance of mitochon-
drial dynamics in maintaining axonal integrity. Axonal 
degeneration causes functional impairments and often 
precedes neuronal cell death. We evaluated mechanisms 
of axonal degeneration induced by capsaicin, an analgesic 
which has been shown to induce distal axonal degenera-
tion. Capsaicin activates TRPV1. When activated, TRPV1 
mediates a rapid increase in axoplasmic Ca2+ [9, 64]. Our 
results demonstrate that capsaicin induces axonal degen-
eration through Ca2+-dependent alterations in mitochon-
drial dynamics. The rescue of axonal survival by inhibi-
tion of mitochondrial fission provides further evidence 
that mitochondria are actively involved in axonal degen-
eration (Fig. 9a–d). Our model shares important aspects 
of the axonal swellings and dying-back axonal degenera-
tion described in genetic neurodegenerative diseases [17, 
28], including hereditary spastic paraplegia (HSP) [6] and 
Charcot–Marie–Tooth disease [53]. HSP is caused by a 
variety of gene mutations, including genes specific for 
myelin (proteolipid protein), axonal transport (kinesis), 
smooth endoplasmic reticulum (reticulin) and mitochon-
dria (heat shock protein 60, paraplegin, and mitofusin2) [6, 
17, 48, 51, 81]. Despite this diversity in mutated genes, the 
pathological hallmark of HSP is a dying-back axonopathy 
that is mediated in part by chronic increases in axoplas-
mic Ca2+. Defects in mitochondrial genes or functions are 
also documented in non-hereditary chronic neurodegenera-
tive diseases [38, 59, 63]. Diabetic sensory neuropathies, 
with significant distal axonal loss and reduced mitochon-
drial functions in both humans [35, 42] and animal mod-
els [15, 65], add additional support for the interdependence 
between mitochondria and axonal integrity. In contrast 
to chronic neurodegenerative diseases, capsaicin acutely 
induces axonal degeneration by increasing axoplasmic 
Fig. 9  Proposed model for the role of mitochondrial fission in cap-
saicin-induced axonal degeneration. a Activation of TRPV1 increases 
axoplasmic Ca2+, induces Drp1-mediated mitochondrial fission, 
reduces mitochondrial membrane potential, and increases axonal 
swellings (c) and axonal degeneration (d). b When mitochondrial fis-
sion is prevented by mutant Drp1K38A overexpression, axonal mito-
chondria retain normal lengths and sustain membrane potentials. This 
correlates with decreased axonal ovoid formation and axonal degen-
eration upon capsaicin treatment
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Ca2+. Given the difficulties in manipulating mitochondrial 
changes in chronic models of axonal degeneration, this 
report describes an acute system which can be tested and 
easily regulated in vitro. The capsaicin model shares funda-
mental aspects of chronic axonal degeneration.
In conclusion, we demonstrate a critical role for mito-
chondrial dynamics in axonal ovoid formation and subse-
quent axonal degeneration by altering fusion and fission. 
Axonal ovoid formation induced by increased axoplas-
mic Ca2+ can be modulated by a Drp1-mediated pathway, 
which impacts axonal survival. Thus, our capsaicin model 
is simple, easily regulated, and provides a paradigm to 
rescue axons upon cationic overload in neurodegenerative 
diseases.
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